Anemia: Classification and Pathophysiology

Core Idea

Anemia is reduced hemoglobin causing decreased oxygen-carrying capacity. Classification by RBC morphology (microcytic, normocytic, macrocytic) or mechanism (blood loss, decreased production, increased destruction) guides diagnosis. Compensatory mechanisms include increased cardiac output and increased 2,3-DPG.

How It's Best Learned

Use the reticulocyte count and peripheral blood smear to classify. Correlate MCV with iron, B12, and folate status. Understand that anemia is a sign, not a diagnosis—identify and treat the underlying cause.

Common Misconceptions

Hemoglobin of 10 g/dL is not necessarily symptomatic—chronic anemia is tolerated; acute anemia causes symptoms at higher levels. Microcytosis does not always indicate iron deficiency; chronic disease and thalassemia trait must be considered.

Explainer

Anemia is defined by the final result — insufficient hemoglobin to carry enough oxygen — but it is a consequence, not a cause, and understanding it requires working backward through mechanism. Red blood cells are essentially hemoglobin-filled containers whose job is oxygen transport, and iron sits at the center of the heme molecule that binds oxygen. You know from your prerequisites that iron cycles tightly through storage (ferritin), transport (transferrin), and incorporation into hemoglobin. Anemia occurs whenever this system fails to maintain adequate hemoglobin — through too little production, too much destruction, or blood loss.

The first diagnostic step is morphology: looking at RBC size tells you which part of the production pathway failed. Microcytic anemia (small cells, low MCV) points to a problem with hemoglobin synthesis — most commonly iron deficiency, but also chronic disease or thalassemia trait. Without enough iron, cells make less hemoglobin per cell and must compensate by dividing more, producing smaller cells. Macrocytic anemia (large cells, high MCV) points to impaired DNA synthesis, which slows cell division without slowing cytoplasm growth — the cell grows large before it can divide. This is the mechanism behind B12 and folate deficiency, which impairs nucleotide synthesis. Normocytic anemia with a low reticulocyte count implies a production problem from the marrow; with a high reticulocyte count it implies acute blood loss or hemolysis — the marrow is working hard but losing the race.

The body's compensatory response to anemia reflects fundamental physiology: when oxygen delivery falls, the body works to maximize what oxygen it can extract. Cardiac output increases to circulate blood faster, explaining fatigue, dyspnea, and palpitations. The kidneys respond to hypoxia by releasing erythropoietin, signaling the marrow to accelerate red cell production. Inside the red cell, 2,3-DPG accumulates — this molecule binds hemoglobin and shifts the oxygen-dissociation curve rightward, reducing oxygen affinity and making it easier to unload oxygen to tissues. Chronic anemia is often well-tolerated because these compensations have time to develop; acute blood loss is dangerous because they haven't.

The diagnostic algorithm is therefore a decision tree: check hemoglobin to confirm anemia, check MCV to classify morphology, check reticulocyte count to assess marrow response, then use targeted tests (serum iron and ferritin for iron deficiency, B12 and methylmalonic acid for B12 deficiency, peripheral smear and LDH for hemolysis) to identify the underlying cause. The point emphasized in the Common Misconceptions section — that anemia is a sign, not a diagnosis — is not just a semantic nicety. It directs the entire clinical workflow: the classification system exists to point you toward the specific underlying cause, each of which requires its own treatment.